ResMed Revenue 2006-2019 | RMD

ResMed annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • ResMed revenue for the quarter ending September 30, 2019 was $0.681B, a 15.77% increase year-over-year.
  • ResMed revenue for the twelve months ending September 30, 2019 was $2.699B, a 12.25% increase year-over-year.
  • ResMed annual revenue for 2019 was $2.607B, a 11.38% increase from 2018.
  • ResMed annual revenue for 2018 was $2.34B, a 13.23% increase from 2017.
  • ResMed annual revenue for 2017 was $2.067B, a 12.4% increase from 2016.
ResMed Annual Revenue
(Millions of US $)
2019 $2,607
2018 $2,340
2017 $2,067
2016 $1,839
2015 $1,679
2014 $1,555
2013 $1,514
2012 $1,369
2011 $1,243
2010 $1,092
2009 $921
2008 $835
2007 $716
2006 $607
2005 $426
ResMed Quarterly Revenue
(Millions of US $)
Q1 2019 $681
Q4 2019 $705
Q3 2019 $662
Q2 2018 $651
Q1 2018 $588
Q4 2018 $624
Q3 2018 $592
Q2 2017 $601
Q1 2017 $524
Q4 2017 $557
Q3 2017 $514
Q2 2016 $530
Q1 2016 $465
Q4 2016 $519
Q3 2016 $454
Q2 2015 $455
Q1 2015 $412
Q4 2015 $453
Q3 2015 $422
Q2 2014 $423
Q1 2014 $380
Q4 2014 $415
Q3 2014 $398
Q2 2013 $384
Q1 2013 $358
Q4 2013 $415
Q3 2013 $384
Q2 2012 $377
Q1 2012 $340
Q4 2012 $372
Q3 2012 $349
Q2 2011 $333
Q1 2011 $315
Q4 2011 $342
Q3 2011 $313
Q2 2010 $306
Q1 2010 $282
Q4 2010 $292
Q3 2010 $279
Q2 2009 $275
Q1 2009 $247
Q4 2009 $252
Q3 2009 $228
Q2 2008 $223
Q1 2008 $218
Q4 2008 $235
Q3 2008 $212
Q2 2007 $203
Q1 2007 $186
Q4 2007 $191
Q3 2007 $183
Q2 2006 $178
Q1 2006 $164
Q4 2006 $171
Q3 2006 $162
Q2 2005 $146
Q1 2005 $127
Q4 2005 $125
Q3 2005 $108
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.088B $2.607B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $159.545B 22.04
Abbott Laboratories (ABT) United States $157.393B 28.71
Stryker (SYK) United States $79.374B 26.69
Boston Scientific (BSX) United States $61.719B 29.13
Baxter (BAX) United States $45.812B 27.78
Essilor Luxottica (ESLOY) France $35.128B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.725B 19.27
Lonza Group Ag (LZAGY) Switzerland $28.134B 0.00
Coloplast (CLPBY) Denmark $27.648B 42.67
Terumo (TRUMY) Japan $26.986B 33.68
Smith & Nephew SNATS (SNN) United Kingdom $21.557B 0.00
Sunny Optical Technology (SNPTF) China $20.017B 0.00
Insulet (PODD) United States $11.669B 555.18
Bio-Rad Laboratories (BIO) United States $11.282B 54.15
Canopy Growth (CGC) Canada $8.676B 0.00
Perrigo (PRGO) Ireland $8.033B 14.98
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Hill-Rom Holdings (HRC) United States $7.750B 22.78
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
GN STORE NORD (GNNDY) Denmark $6.158B 31.81
Haemonetics (HAE) United States $5.770B 38.99
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.065B 32.01
ICU Medical (ICUI) United States $3.960B 25.81
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.923B 0.00
Neogen (NEOG) United States $3.757B 62.53
GW Pharmaceuticals (GWPH) United Kingdom $3.675B 0.00
Agios Pharmaceuticals (AGIO) United States $3.113B 0.00
Quidel (QDEL) United States $3.020B 28.66
National Vision Holdings (EYE) United States $2.597B 58.63
Aurora Cannabis (ACB) Canada $2.321B 0.00
Cardiovascular Systems (CSII) United States $1.887B 0.00
AtriCure (ATRC) United States $1.513B 0.00
InMode (INMD) Israel $1.440B 0.00
TG Therapeutics (TGTX) United States $1.364B 0.00
Aphria (APHA) $1.331B 0.00
VAREX IMAGING (VREX) United States $1.206B 24.09
NanoString Technologies (NSTG) United States $1.101B 0.00
Phibro Animal Health (PAHC) United States $1.043B 19.54
PetIQ (PETQ) United States $0.869B 21.20
Eagle Pharmaceuticals (EGRX) United States $0.806B 30.87
Lantheus Holdings (LNTH) United States $0.742B 18.54
LeMaitre Vascular (LMAT) United States $0.737B 41.43
Omeros (OMER) United States $0.678B 0.00
Quanterix (QTRX) United States $0.675B 0.00
Cerus (CERS) United States $0.571B 0.00
Surmodics (SRDX) United States $0.560B 58.06
MacroGenics (MGNX) United States $0.551B 0.00
Organigram Holdings (OGI) Canada $0.509B 0.00
OraSure Technologies (OSUR) United States $0.507B 30.44
HEXO (HEXO) $0.441B 0.00
Meridian Bioscience (VIVO) United States $0.424B 14.54
Utah Medical Products (UTMD) United States $0.392B 28.37
Zynex (ZYXI) United States $0.350B 39.59
Owens & Minor (OMI) United States $0.346B 12.81
BioLife Solutions (BLFS) United States $0.332B 135.08
Neptune Wellness Solutions (NEPT) Canada $0.285B 0.00
Bovie Medical (APYX) United States $0.277B 0.00
Female Health (VERU) United States $0.273B 0.00
Vapotherm (VAPO) United States $0.259B 0.00
United Health Products (UEEC) United States $0.233B 0.00
Repro-Med Systems (KRMD) United States $0.225B 0.00
Viemed Healthcare (VMD) United States $0.209B 22.04
Green Organic Dutchman Holdings (TGODF) Canada $0.178B 0.00
Liberty Health Sciences (LHSIF) Canada $0.177B 0.00
Rockwell Medical (RMTI) United States $0.166B 0.00
Cytosorbents (CTSO) United States $0.149B 0.00
Fonar (FONR) United States $0.134B 9.43
Chimerix (CMRX) United States $0.125B 0.00
MTech Acquisition (KERN) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.095B 0.00
Surface Oncology (SURF) United States $0.094B 0.00
United-Guardian (UG) United States $0.089B 22.57
MRI Interventions (MRIC) United States $0.086B 0.00
Nephros (NEPH) United States $0.074B 0.00
Chembio Diagnostics (CEMI) United States $0.069B 0.00
FSD PHARMA INC (HUGE) $0.051B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.025B 0.00
GUARDION HEALTH (GHSI) United States $0.023B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Senestech (SNES) United States $0.016B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00